Vaylen vs Telos Rx: Price, formats, and refund differences
Vaylen vs Telos Rx pits two cash-pay telehealth programs offering compounded semaglutide and tirzepatide. Early verdict: Vaylen emphasizes lower prepaid 12 month rates and a pay-first full refund if a clinician declines, while Telos Rx publishes as-low-as monthly rates with a pay-0-if-not-approved message and simpler month-to-month phrasing.
See Vaylen pricing and 12 month plans
Quick comparison: enrollment model and pricing
The key difference between Vaylen and Telos Rx is how pricing and enrollment are structured. Vaylen advertises annualized, prepaid 12 month plans billed upfront with semaglutide injections from $83.25 per month on that plan or $224 per month month to month. Telos Rx publishes semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with statements that pricing applies if a licensed provider approves you.
Check Telos Rx current pricing
Three distinctive differences
1. Prepay 12 month plans versus as-low-as monthly pricing
Vaylen: headline rates such as $83.25 per month for semaglutide are annualized on a 12 month plan billed upfront. Vaylen states each 12 month rate is paid before clinician review and offers a full refund if the clinician declines to prescribe for that billing cycle. Telos Rx: lists semaglutide as low as $99 per month and tirzepatide as low as $139 per month, framed as conditional on a US licensed provider approving you. Telos Rx also states pay 0 if not approved in its captured material.
Start Vaylen enrollment and learn refund terms
2. Treatment formats offered
Both providers offer compounded semaglutide and tirzepatide, but Vaylen explicitly lists three formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide. Vaylen highlights a needle free oral tablet option at a prepaid 12 month rate of $99 per month. Telos Rx describes semaglutide and tirzepatide options and that a US licensed provider decides which molecule is right for you. Neither provider claim of branded FDA approved finished products is present; both include regulatory notes that compounded medications are not FDA approved.
3. Refunds and cancellation language
Vaylen states a full refund if a clinician declines to prescribe and that the clinician reviews applications within 24 hours. Vaylen also states shipping is free and discreet in 1 to 3 business days and that billing is upfront for 12 month plans. Telos Rx captured content includes the phrase pay 0 if not approved and cancel anytime with no penalties in its captured landing material, but many operational details such as renewal terms, pharmacy and state coverage were not published or could not be verified on the captured affiliate landing page.
Comparison table
| Criteria | Vaylen | Telos Rx |
|---|---|---|
| Semaglutide starting rate | $83.25/mo on 12 month plan or $224/mo month to month | As low as $99 per month |
| Tirzepatide starting rate | $149/mo on 12 month plan or $299/mo month to month | As low as $139 per month |
| Formats | Weekly injections, daily oral tablet, weekly tirzepatide | Semaglutide and tirzepatide compounded options |
| Payment timing | Prepay 12 month plans billed upfront; month to month option available | As low as monthly rates; captured material says pay 0 if not approved |
| Refund / approval promise | Full refund for that billing cycle if clinician declines | Captured content states pay 0 if not approved; other details not published |
| Shipping and turnaround | Free discreet shipping in 1 to 3 business days; clinician review within 24 hours | Not published or could not be verified on captured page |
Other practical differences to weigh
Vaylen emphasizes bundle pricing and published prepaid totals such as $999 for a 12 month semaglutide plan and communicates that clinicians are LegitScript certified via OpenLoop Health and available in all 50 states. Vaylen also notes the oral tablet costs about $16 more per month than the injectable version of the same molecule on its prepaid plan. Telos Rx material repeatedly notes that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that individual results vary and are not guaranteed. The captured Telos Rx content did not publish an expanded FAQ or the same level of shipping timelines found in Vaylen materials.
Safety and regulatory notes
Both providers include the regulatory disclosure that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. Both state prescription and clinician approval are required to receive compounded GLP 1 medications.
Conclusion and who should choose which
Vaylen vs Telos Rx comes down to enrollment model, price certainty and format breadth. Choose Vaylen if you want the lowest advertised prepaid 12 month semaglutide rate, a needle free oral tablet option on the same platform, and a published full refund if a clinician declines. Choose Telos Rx if you prefer pricing presented as as low as monthly rates and messaging that emphasizes pay 0 if not approved and month to month framing, while confirming eligibility, renewal terms and state availability before enrolling.